MedTrace Logo

Prophylactic Treatment of Sleep/Fatigue Before and During Chemotherapy

NCT01542983 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-01-24

No results posted yet for this study

Summary

Women with breast cancer complain of poor sleep and fatigue during chemotherapy which affect their mood, their memory and their quality of life. The investigators are testing whether it is feasible to treat the poor sleep and fatigue with behavioral treatments, before the start of chemotherapy and whether improving sleep and fatigue will also improve mood, memory and quality of life.

Conditions

  • Stage, Breast Cancer

Interventions

BEHAVIORAL

Brief behavioral treatment for insomnia and bright light

daily bright light exposure; 2 sessions for insomnia

BEHAVIORAL

treatment as usual

Standard treatment for fatigue and insomnia

Sponsors & Collaborators

Principal Investigators

  • Sonia Ancoli-Israel, PhD · UCSD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01542983 on ClinicalTrials.gov